References
- Pyorala K, Laakso M. Diabetes and atherosclerosis: an epidemiologic review. Diabetes Metab Rev 1987;3:463–524.
- Berg K. A new serum type system in man-the LP-system. Acta Pathol Microbiol Scand 1963;59:369–89.
- Mbewu A, Durrington PN. Lipoprotein a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 1990;85:1–14.
- Hassted SJ, Williams RR. Three alleles for qantitative lpa). Genet Epidemiol 1986;3:53–5.
- Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein lpa) in hyperlipidaemic sub-jects treated with nicotinic acid. J Intern Med 1989;226:271–6.
- Selby JV. Environmental and behavioural influences on plasma lpa). Prey Med 1994;23:345–53.
- Berg K, Rø OC. Lpa) lipoprotein and longevity. Ann Genet 1991;34:264–9.
- Utermann G. The mysteries of lipoprotein a). Science 1989;246:904–10.
- Berg K. Inherited lipoprotein variation and atherosclerotic disease. In: Scanu AM, Wissler RW, Getz GS, editors. The biochemistry of atherosclerosis. New York: Marcel Dekker, 1979.
- Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Med 1988;5: 126–34.
- Kapelrud H, Bangstad H-J, Dahl-Jorgensen K, Berg K, Hanssen KF. Serum Lpa) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. BMJ 1991;303:675–8.
- Jenkins AJ, Steele JS, Janus ED, Santamaria JD, Best JD. Increased plasma apoa) in patients with type 2 diabetes and microalbuminuria. Ninth International Symposium on Atherosclerosis. Rosemont, IL, 6–11 October 1991; 173: 274.
- Rhoads GG, Dahlen G, Berg K, Morton NE, Danneberg AL. Lpa) lipoprotein as a risk factor for myocardial infarc-tion. JAMA 1986;256:2540–4.
- Haffner SM, Morales PA, Stern MP, Gruber MK. Lpa) concentrations in NIDDM. Diabetes 1992;41:1267–72.
- Haffner SM, Moss SE, Klein BEK, Klein R. Lack of association between lpa) concentrations and coronary heart disease mortality in diabetes: The Wisconsin Epi-demiologic Study of Diabetic Retinopathy. Metabolism 1992;41:194–7.
- Bruckert E, Davidoff P, Grimaldi A, Truffert J, Giral P, Doumith P, et al. Increased serum lipoproteina) in diabetes mellitus and their reduction with glycemic control letter). JAMA 1990;263:35–6.
- Garber AJ, Jones PH, Ghanem KK, Morrisett JD. Re-sponse of plasma lipoproteina) levels to diabetes control therapy. Ninth International Symposium on Atherosclero-sis. Rosemont, IL, 6–11 October 1991;12.
- Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Associations of levels of lipoprotein lpa), plasma lipids, and other lipoproteins with coronary heart disease documented by angiography. Circulation 1986;74:758–65.
- O'Brien T, Nguyen TT, Harrison JM, Bailey KR, Dyck PJ, Kottke BA. Lipids and lpa) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent dia-betes mellitus. Mayo Clin Proc 1994;69:430–5.
- Parving H-H, Gall M-A, Skott P, Jorgensen HE, Lokkegárd H, Jorgensen F, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992;41:1–5.